US BANCORP \DE\ - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$13,187
+14.1%
1,446
+32.4%
0.00%
Q2 2023$11,553
+6.7%
1,092
+23.4%
0.00%
Q1 2023$10,824
-46.2%
885
-45.4%
0.00%
Q4 2022$20,117
+0.6%
1,621
+12.3%
0.00%
Q3 2022$20,000
+900.0%
1,444
+977.6%
0.00%
Q2 2022$2,000
-80.0%
134
-78.2%
0.00%
Q1 2022$10,000
-37.5%
614
-27.5%
0.00%
Q3 2021$16,000
+128.6%
847
+182.3%
0.00%
Q2 2021$7,000300
+1775.0%
0.00%
Q1 2021$0
-100.0%
16
-79.2%
0.00%
Q4 2020$3,000770.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders